Research Group
Scott lab group, August 2009.
Back row, left to right: Dr. Emily Scott, Kathy Meneely, Natasha DeVore, Aaron BartFront row, left to right: Aggi Walsh, Eva Stephens, Linda Blake, Megen Culpepper
Aaron Bart
is a senior majoring in Biochemistry at KU. He is learning and contributing
to understanding the enzymology of cytochrome P450 enzymes from the CYP2A subfamily.
Linda Blake
graduated summa cum laude with a B.S. in Chemistry from
Seattle Pacific University and is currently a Ph.D. student in the
KU Department of Medicinal Chemistry. Linda is the recipient of an
AFPE fellowship. Her current research project focuses on the development
of selective and potent inhibitors of human cytochrome P450 2A13 as a
chemopreventative of nicotine-associated lung cancer. This research
won an award at the KU Graduate Research Symposium.
Eric Carrillo
is a Pharm.D. student at the University of Kansas. He is working on the
application of new biophysical techniques to cytochrome P450 enzymes.
Megen Miller Culpepper
earned a Ph.D. in Chemistry from KU for research on the structure and function
of prolyl-4-hydroxylase from Bacillus anthracis. She is currently a postdoctoral
fellow in the Scott laboratory.
Natasha Michno DeVore
graduated summa cum laude with a B.A. in Chemistry from Evangel University.
Natasha then earned a M.S. in Medicinal Chemistry for her research in the
Scott Lab working on the functional and structural differences between the
human cytochrome P450 enzymes 2A6 and 2A13. Now a Ph.D.
student in KU Molecular Biosciences, Natasha is continuing research in the
Scott Lab working on several other human cytochrome P450 enzymes using both
structural and functional approaches. Natasha is the recipient of a Bishop Scholarship.
Kathy Meneely
earned both a B.S. and a Ph.D. from the University of Kansas Department of Molecular
Biosciences. Her Ph.D. training in the laboratory of Dr. Audrey Lamb focused on the
enzymology of siderophores. She is currently a postdoctoral fellow in the Scott
laboratory working on a variety of structural projects involving cytochrome P450 2E1.
Eva Stephens
graduated with a B.S. in Biochemistry from Rockhurst University and is currently a Ph.D.
student in the Department of Medicinal Chemistry at KU. Eva is the recipient of a Smissman
Fellowship. She is currently undertaking research to define the interactions of human
CYP2A enzymes with a panel of inhibitors.
Aggi Walsh
earned a B.A. in Biological Sciences from Brandeis. She earned a Ph.D. in Pharmacology and
Toxicology from the University of California Davis for research focused on the regulation of
cytochrome P450 enzymes. In the Scott Laboratory she is pursuing expression and purification
of a variety of cytochrome P450 enzymes.